CN105918607A - Soybean whey protein composite powder and preparation method thereof - Google Patents
Soybean whey protein composite powder and preparation method thereof Download PDFInfo
- Publication number
- CN105918607A CN105918607A CN201610272434.6A CN201610272434A CN105918607A CN 105918607 A CN105918607 A CN 105918607A CN 201610272434 A CN201610272434 A CN 201610272434A CN 105918607 A CN105918607 A CN 105918607A
- Authority
- CN
- China
- Prior art keywords
- powder
- protein
- soybean
- whey
- content
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 168
- 239000002131 composite material Substances 0.000 title claims abstract description 38
- 102000007544 Whey Proteins Human genes 0.000 title claims abstract description 29
- 108010046377 Whey Proteins Proteins 0.000 title claims abstract description 29
- 235000021119 whey protein Nutrition 0.000 title claims abstract description 29
- 235000010469 Glycine max Nutrition 0.000 title claims abstract description 24
- 244000068988 Glycine max Species 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 235000018102 proteins Nutrition 0.000 claims abstract description 52
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 52
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 52
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 48
- 102000008186 Collagen Human genes 0.000 claims abstract description 34
- 108010035532 Collagen Proteins 0.000 claims abstract description 34
- 241000251468 Actinopterygii Species 0.000 claims abstract description 31
- 239000012141 concentrate Substances 0.000 claims abstract description 26
- 229960003080 taurine Drugs 0.000 claims abstract description 24
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 17
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 17
- 108010073771 Soybean Proteins Proteins 0.000 claims description 31
- 235000019710 soybean protein Nutrition 0.000 claims description 31
- 210000000582 semen Anatomy 0.000 claims description 28
- 241000209094 Oryza Species 0.000 claims description 23
- 235000007164 Oryza sativa Nutrition 0.000 claims description 23
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 23
- 235000009566 rice Nutrition 0.000 claims description 23
- 235000013312 flour Nutrition 0.000 claims description 22
- 230000001954 sterilising effect Effects 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 15
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 14
- 229940083466 soybean lecithin Drugs 0.000 claims description 14
- 239000000835 fiber Substances 0.000 claims description 10
- 239000000126 substance Substances 0.000 claims description 9
- 101100449517 Arabidopsis thaliana GRH1 gene Proteins 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- 101100434479 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) AFB1 gene Proteins 0.000 claims description 8
- 241000607142 Salmonella Species 0.000 claims description 8
- 241000607768 Shigella Species 0.000 claims description 8
- 241000191967 Staphylococcus aureus Species 0.000 claims description 8
- 108010046334 Urease Proteins 0.000 claims description 8
- OQIQSTLJSLGHID-WNWIJWBNSA-N aflatoxin B1 Chemical compound C=1([C@@H]2C=CO[C@@H]2OC=1C=C(C1=2)OC)C=2OC(=O)C2=C1CCC2=O OQIQSTLJSLGHID-WNWIJWBNSA-N 0.000 claims description 8
- 229930020125 aflatoxin-B1 Natural products 0.000 claims description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052782 aluminium Inorganic materials 0.000 claims description 8
- 229910052785 arsenic Inorganic materials 0.000 claims description 8
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims description 8
- 239000008101 lactose Substances 0.000 claims description 8
- 210000000481 breast Anatomy 0.000 claims description 7
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 1
- 241000283690 Bos taurus Species 0.000 claims 1
- 108010028690 Fish Proteins Proteins 0.000 claims 1
- 235000019784 crude fat Nutrition 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 6
- 235000012000 cholesterol Nutrition 0.000 abstract description 5
- 235000015097 nutrients Nutrition 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 3
- 244000077995 Coix lacryma jobi Species 0.000 abstract description 2
- 235000004213 low-fat Nutrition 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 230000002335 preservative effect Effects 0.000 abstract description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 235000010445 lecithin Nutrition 0.000 abstract 1
- 239000000787 lecithin Substances 0.000 abstract 1
- 229940067606 lecithin Drugs 0.000 abstract 1
- 239000000047 product Substances 0.000 description 24
- 235000019197 fats Nutrition 0.000 description 11
- 230000036039 immunity Effects 0.000 description 9
- 230000036541 health Effects 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 230000036737 immune function Effects 0.000 description 6
- 230000002906 microbiologic effect Effects 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 241000700605 Viruses Species 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229960002591 hydroxyproline Drugs 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 230000001473 noxious effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 2
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 108010064719 Oxyhemoglobins Proteins 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 101710093788 Protein O-mannosyl-transferase 2 Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000015177 dried meat Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- -1 hydroxyl Amino Chemical group 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001009 osteoporotic effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000505 pernicious effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/04—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from fish or other sea animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/14—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from leguminous or other vegetable seeds; from press-cake or oil-bearing seeds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
Abstract
The invention relates to soybean whey protein composite powder and a preparation method thereof. The soybean whey protein composite powder comprises, by weight, 5-10 parts of soy isolate protein powder, 12-20 parts of whey protein concentrate powder, 3-10 parts of fish collagen protein powder and 0.5-2 parts of taurine. In preparation, the soy isolate protein powder, whey protein concentrate powder and fish collagen protein powder are mixed according to the weight part ratio, other components are added into the mixture through a fluidized bed, the mixture is subjected to granulation, and the product is collected and is sterilized so that a finished product is obtained. Compared with the prior art, the preparation method utilizes soy isolate protein powder, whey protein concentrate powder and fish collagen protein powder as main raw material and uses taurine, coix seed powder, poria cocos powder, soya bean lecithin and soybean oligosaccharides so that the soybean whey protein composite powder is rich in comprehensive and balanced nutrients, has high protein content, is pure natural, does not produce pollution, does not contain a preservative, contains multiple natural active components, has low cholesterol content, low fat content and low heat and fast supplies comprehensive nutrients.
Description
Technical field
The invention belongs to technical field of health care food, relate to a kind of whey-soybean albumen composite powder and preparation method thereof.
Background technology
Immunity, from biology from the point of view of, refer to resist the ability of disease development.Immunity is human body self
Defense mechanism, is human bioequivalence and any foreign body (virus, antibacterial etc.) eliminating external intrusion；Process aging,
Damage, dead, the own cells of degeneration and identification and process vivo mutations cell and the ability of virus infected cell.
Immunology Today is thought, immunity is human bioequivalence and the physiological reaction getting rid of " dissident ".
Human lives, in a complex environment, suffer from the attack of various pathogen, bag
Include antibacterial, virus, fungus and parasite etc..Although human body has an a lot of immunity defence line resist the disease, but human body
The height of immunity can be often subject to the impact of various factors, and many destructive stimuluses can cause immunity to reduce, as
The emotion such as fatigue, chronic disease, malnutrition, psychentonia, anxiety stimulates, and environmental pollution and certain
A little medicines etc. all can insulting normal immunological function.When immune function of human body is lacked of proper care, or immune system is not good for
Generation that is full-time, that will give rise to diseases, such as: flu, asthma, bronchitis, pneumonia, diarrhoea, cancer
Etc..
Along with improving constantly of living standards of the people, health is increasingly paid attention to by people, ill from the past
Passive treatment is changed into anosis active prevention, and increasing people is by supplementing some health product targetedly in good time
Improve the immunologic function of self, to reach the health secured good health.
It is known that protein is one of nutrient of needed by human.The protein deficient that human body is taken in can cause
The generation of relevant disease, such as physiological metabolism disorder, immunologic function degression, growth retardation etc., therefore supplements one
Quantitative protein has potentiation to the immunity of human body.At present, people eat protein powder mostly be animal
Property protein refine and form, containing substantial amounts of excess saturated fat, cholesterol, high heat, and in processing technique
With the addition of substantial amounts of food additive such as pigment, sweeting agent, preservative etc., therefore give while supplementary protein
Human body brings some other harm.Semen sojae atricolor is the source of the high quality vegetable protein that people are conventionally recognized by, containing abundant
Aminoacid, wherein have 8 kinds of aminoacid of needed by human.Soybean protein isolate as food process raw material or
Additive is widely used in food and field of health care products, but current production technology application soybean protein isolate is raw
The Semen sojae atricolor powder dissolubility produced, poor stability, and particle surface is uneven, reconstitutes uneven, easily occur conglomeration,
Lamination.It addition, current soybean protein powder product is mostly only with single soybean protein or lactalbumin,
Easily cause aminoacid composition comprehensive not, the phenomenon of each nutritional labeling composition equilibrium not.
Summary of the invention
Defect that the purpose of the present invention is contemplated to overcome above-mentioned prior art to exist and provide a kind of containing multiple sky
So active component, green health, nutrition whey-soybean albumen composite powder more rich, that more comprehensively, more equalize and
Preparation method.
The purpose of the present invention can be achieved through the following technical solutions:
A kind of whey-soybean albumen composite powder, this albumen composite powder includes following components and weight portion content: Semen sojae atricolor is divided
From egg albumen powder 5-10 part, whey protein concentrate powder 12-20 part, fish collagen protein powder 3-10 part and taurine 0.5-2
Part.
Described albumen composite powder also includes Semen Coicis rice flour 0.5-1 part, Poria powder 0.1-1 part, soybean lecithin 0.5-1
Part and soybean oligo saccharide 0.2-0.6 part.
As preferred technical scheme, described albumen composite powder includes following components and weight portion content: Semen sojae atricolor is divided
From egg albumen powder 6.5-9 part, whey protein concentrate powder 12-16 part, fish collagen protein powder 4.5-8 part, taurine 0.6-1.4
Part, Semen Coicis rice flour 0.6-0.7 part, Poria powder 0.1-0.3 part, soybean lecithin 0.6-0.8 part and soybean oligo saccharide
0.2-0.4 part.
As further preferred technical scheme, described albumen composite powder includes following components and weight portion content:
Soybean protein isolate powder 6.6 parts, 12 parts of whey protein concentrate powder, fish collagen protein powder 4.8 parts, taurine 0.6
Part, 0.6 part of Semen Coicis rice flour, Poria powder 0.1 part, soybean lecithin 0.8 part and soybean oligo saccharide 0.2 part.
Biodiversity content≤5% in described soybean protein isolate powder, thick protein mass content >=95%, slightly
Fat mass content≤0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
Protein quality content >=86% in described whey protein concentrate powder, biodiversity content≤5.5%, butterfat
Mass content≤6%, lactose mass content >=12%.
Protein quality content >=94% in described fish collagen protein powder, ash mass content≤5%, bacterium colony is total
Number≤2000cfu/g.
The granularity of described taurine is 60-80 mesh, and described Semen Coicis rice flour and the granularity of Poria powder are 80-100
Mesh.
The preparation method of a kind of whey-soybean albumen composite powder, concentrates soybean protein isolate powder, milk surum by weight
Egg albumen powder and fish collagen protein powder mixing, add other component pelletizes by weight through ebullated bed, control ebullated bed
Inlet temperature be 112-118 DEG C, outlet temperature is 72-78 DEG C, collect product, sterilizing, i.e. prepare finished product.
After sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤3%, total arsenic
≤ 0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；Microorganism
Index is: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g, sramana
Salmonella, shigella, staphylococcus aureus must not detect.
In instant component formula:
Described soybean protein isolate powder is nutritious, without cholesterol, advantageously reduces body's cholesterol with saturated
The intake of fat, stops urine calcium loss, promotes bone health, reduce and suffer from osteoporotic probability.
Described whey protein concentrate powder has maintenance and improves immunity of organisms, free radical resisting slow down aging, maintenance
Renal function and the effect of promotion wound healing, the beneficially health of cardiovascular system.
Described fish collagen protein powder mainly contains I and V collagen type, is distributed in the skin of Fish, bone, squama etc.
Place, is the spirality fiber shape protein twisted into by 3 peptide chains.Its essential amino acid composition is glycine, dried meat ammonia
Acid, hydroxyproline, alanine, hydroxylysine etc., aminoacid composition has significant difference, sweet ammonia with other oroteins
The content of acid is the highest, almost accounts for 1/3rd of total amino acid residue, i.e. every 2 other amino acid residues (X, Y)
I.e. there is 1 glycine, therefore its peptide chain can represent with (Gly-X-Y) n；Its contained hydroxyproline and hydroxyl
Amino acid residue is the rarest in other oroteins.
Described taurine is organized at brain, the heart, liver, kidney, retina, skeletal muscle and the leukocyte etc. of mammal
Rich content in organ, is the free amino acid that people's in-vivo content is the highest.Taurine is not the constituent of protein,
But being a kind of conditionally essential amino acid, it serves not only as a kind of nutrient substance and participates in the growth metabolism of body, and
Participate in maintaining the immunologic function of body, to physiology merits such as nerve, digestion, reproduction, cardiovascular, immunity and endocrine
The normal performance of energy has important regulation effect.
Described Semen Coicis rice flour nutritive value is the highest, containing protein, fat, carbohydrate, crude fibre, ore deposit
Material calcium, phosphorus, ferrum, vitamin B1, vitamin B2, nicotinic acid, starch, leucine, arginine, lysine,
The nutritional labelings such as tyrosine, fatty acid, Semen Coicis ester, Semen Coicis oil, sitosterol, alkaloid.Wherein, protein,
Fat, vitamin B1Content be significantly larger than rice.Component analysis through science is compared, contained by seed of Job's tears
Protein is the highest in standing grain plant seeds, and its carbohydrate, mineral, vitamin B1、B2、E
Deng the most all having more than the several times of common rice, it is possible to be effectively facilitated metabolism, treatment vitamin, mineral
Disease caused by matter deficiency, and the energy needed for vital movement is provided.
Described Poria powder has eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, effect of mind tranquilizing and the heart calming.Dysuria, water can be controlled
Swelling is expired, phlegm retention cough with dyspnea, vomiting, and malignant histocytosis is had loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful disease such as grade.Poria has
Increase superoxide dismutase activity in serum, reduce MDA content, there is cold-resistant, resisting fatigue and defying age is made
With, the immunologic function of human body can not only be significantly improved, and HbO2 Oxyhemoglobin release in blood capillary can be made more
Oxygen, the oxygen that providing organization's cell (including skin, mucosa, hair etc.) is enough, delaying cell aging, make thin
Born of the same parents' rapid regeneration, skin care, increase elastic and gloss, thus play enhancing youthful vigor and beautification function.
Described soybean lecithin has regulation blood fat, the liver protecting, lifting brain activity, the effect of slow down aging.
Described soybean oligo saccharide, is mainly composed of stachyose, Raffinose, and they are double to the profitable strain of human body intestinal canal
Discrimination bacillus has good proliferation function, works noxious bacteria hardly.Soybean oligo saccharide at intestinal by bifid bar
Bacterium absorbs, and is fermented and is degraded into short-chain fatty acid and some phage speciess, it is suppressed that external source pathogenic bacterium and intestinal
The propagation of interior intrinsic Putrefying bacteria, reduces poisonous tunning and the generation of noxious bacteria enzyme.Pass through soybean oligo saccharide
Bacillus bifidus after sheet propagation, by phosphatidic acid and the Intestinal epithelial cells effect of cooperating, occupies intestinal mucosa table
Face, forms one layer of membranes barriers with protective effect, stops the invasion of pernicious bacteria, plays and improve intestinal ring
Border and the effect of protection intestinal.
Prior art is compared, and whey-soybean albumen composite powder of the present invention is with soybean protein isolate powder, whey protein concentrate
Powder and fish collagen protein powder are primary raw material, add taurine, Semen Coicis rice flour, Poria powder, soybean lecithin and big
Bean oligosaccharide, nutrition is more rich, more comprehensively, more equalizes, and protein content is high, and pure natural is pollution-free, without anticorrosion
Agent, containing multiple active skull cap components, low cholesterol, low fat, low in calories, extra-nutrition is the most comprehensively.
The powder specific surface area of whey-soybean albumen composite powder of the present invention is big, be easily dispersed, absorb fast, stores, transports
Defeated, carry more convenient, preparation method is simple, and dosage is easily controllable；Comfortable taste, stable dosage forms, have very
Good application prospect.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention is described in detail.
Embodiment 1:
The present embodiment whey-soybean albumen composite powder, including following components and weight portion content: soybean protein isolate powder
6.6 part, 12 parts of whey protein concentrate powder, fish collagen protein powder 4.8 parts, taurine 0.6 part, Semen Coicis rice flour 0.6
Part, Poria powder 0.1 part, soybean lecithin 0.8 part and soybean oligo saccharide 0.2 part.
Wherein, biodiversity content≤5% in soybean protein isolate powder, thick protein mass content >=95%, slightly
Fat mass content≤0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
Protein quality content >=86% in whey protein concentrate powder, biodiversity content≤5.5%, butterfat quality contains
Amount≤6%, lactose mass content >=12%.
Protein quality content >=94% in fish collagen protein powder, ash mass content≤5%, total plate count≤2000
cfu/g。
The granularity of taurine is 60 mesh, and the granularity of Semen Coicis rice flour and Poria powder is 80 mesh.
The preparation method of the present embodiment whey-soybean albumen composite powder is: by weight by soybean protein isolate powder, breast
Clear concentrated protein powder and fish collagen protein powder mixing, add other component pelletizes by weight through ebullated bed, control
The inlet temperature of ebullated bed is 115 DEG C, and outlet temperature is 76 DEG C, collects product, sterilizing, i.e. prepares finished product.
After the present embodiment sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤
3%, total arsenic≤0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；
Microbiological indicator is: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g,
Salmonella, shigella, staphylococcus aureus must not detect.
Embodiment 2:
The present embodiment whey-soybean albumen composite powder, including following components and weight portion content: soybean protein isolate powder
9 parts, 15 parts of whey protein concentrate powder, fish collagen protein powder 4.5 parts, taurine 1.4 parts, Semen Coicis rice flour 0.7
Part, Poria powder 0.3 part, soybean lecithin 0.6 part and soybean oligo saccharide 0.4 part.
Wherein, biodiversity content≤5% in soybean protein isolate powder, thick protein mass content >=95%, slightly
Fat mass content≤0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
Protein quality content >=86% in whey protein concentrate powder, biodiversity content≤5.5%, butterfat quality contains
Amount≤6%, lactose mass content >=12%.
Protein quality content >=94% in fish collagen protein powder, ash mass content≤5%, total plate count≤2000
cfu/g。
The granularity of taurine, Semen Coicis rice flour and Poria powder is 80 mesh.
The preparation method of the present embodiment whey-soybean albumen composite powder is: by weight by soybean protein isolate powder, breast
Clear concentrated protein powder and fish collagen protein powder mixing, add other component pelletizes by weight through ebullated bed, control
The inlet temperature of ebullated bed is 112 DEG C, and outlet temperature is 72 DEG C, collects product, sterilizing, i.e. prepares finished product.
After the present embodiment sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤
3%, total arsenic≤0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；
Microbiological indicator is: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g,
Salmonella, shigella, staphylococcus aureus must not detect.
Embodiment 3:
The present embodiment whey-soybean albumen composite powder, including following components and weight portion content: soybean protein isolate powder
6.5 part, 16 parts of whey protein concentrate powder, fish collagen protein powder 8 parts, taurine 1.2 parts, Semen Coicis rice flour 0.5
Part, Poria powder 0.2 part, soybean lecithin 0.7 part and soybean oligo saccharide 0.3 part.
Wherein, biodiversity content≤5% in soybean protein isolate powder, thick protein mass content >=95%, slightly
Fat mass content≤0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
Protein quality content >=86% in whey protein concentrate powder, biodiversity content≤5.5%, butterfat quality contains
Amount≤6%, lactose mass content >=12%.
Protein quality content >=94% in fish collagen protein powder, ash mass content≤5%, total plate count≤2000
cfu/g。
Taurine granularity is 80 mesh, and the granularity of Semen Coicis rice flour and Poria powder is 100 mesh.
The preparation method of the present embodiment whey-soybean albumen composite powder is: by weight by soybean protein isolate powder, breast
Clear concentrated protein powder and fish collagen protein powder mixing, add other component pelletizes by weight through ebullated bed, control
The inlet temperature of ebullated bed is 118 DEG C, and outlet temperature is 78 DEG C, collects product, sterilizing, i.e. prepares finished product.
After the present embodiment sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤
3%, total arsenic≤0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；
Microbiological indicator is: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g,
Salmonella, shigella, staphylococcus aureus must not detect.
Embodiment 4:
The present embodiment whey-soybean albumen composite powder, including following components and weight portion content: soybean protein isolate powder
5 parts, 20 parts of whey protein concentrate powder, fish collagen protein powder 3 parts, taurine 0.5 part, 1 part of Semen Coicis rice flour,
Poria powder 0.5 part, soybean lecithin 0.5 part and soybean oligo saccharide 0.6 part.
Wherein, biodiversity content≤5% in soybean protein isolate powder, thick protein mass content >=95%, slightly
Fat mass content≤0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
Protein quality content >=86% in whey protein concentrate powder, biodiversity content≤5.5%, butterfat quality contains
Amount≤6%, lactose mass content >=12%.
Protein quality content >=94% in fish collagen protein powder, ash mass content≤5%, total plate count≤2000
cfu/g。
Taurine granularity is 70 mesh, and the granularity of Semen Coicis rice flour and Poria powder is 80 mesh.
The preparation method of the present embodiment whey-soybean albumen composite powder is: by weight by soybean protein isolate powder, breast
Clear concentrated protein powder and fish collagen protein powder mixing, add other component pelletizes by weight through ebullated bed, control
The inlet temperature of ebullated bed is 115 DEG C, and outlet temperature is 75 DEG C, collects product, sterilizing, i.e. prepares finished product.
After the present embodiment sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤
3%, total arsenic≤0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；
Microbiological indicator is: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g,
Salmonella, shigella, staphylococcus aureus must not detect.
Embodiment 5:
The present embodiment whey-soybean albumen composite powder, including following components and weight portion content: soybean protein isolate powder
10 parts, 16 parts of whey protein concentrate powder, fish collagen protein powder 10 parts, taurine 2 parts, 1 part of Semen Coicis rice flour,
Poria powder 1 part, soybean lecithin 1 part and soybean oligo saccharide 0.5 part.
Wherein, biodiversity content≤5% in soybean protein isolate powder, thick protein mass content >=95%, slightly
Fat mass content≤0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
Protein quality content >=86% in whey protein concentrate powder, biodiversity content≤5.5%, butterfat quality contains
Amount≤6%, lactose mass content >=12%.
Protein quality content >=94% in fish collagen protein powder, ash mass content≤5%, total plate count≤2000
cfu/g。
Taurine granularity is 70 mesh, and the granularity of Semen Coicis rice flour and Poria powder is 80 mesh.
The preparation method of the present embodiment whey-soybean albumen composite powder is: by weight by soybean protein isolate powder, breast
Clear concentrated protein powder and fish collagen protein powder mixing, add other component pelletizes by weight through ebullated bed, control
The inlet temperature of ebullated bed is 112 DEG C, and outlet temperature is 75 DEG C, collects product, sterilizing, i.e. prepares finished product.
After the present embodiment sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤
3%, total arsenic≤0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；
Microbiological indicator is: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g,
Salmonella, shigella, staphylococcus aureus must not detect.
Embodiment 6:
The present embodiment whey-soybean albumen composite powder, including following components and weight portion content: soybean protein isolate powder
5 parts, 18 parts of whey protein concentrate powder, fish collagen protein powder 3.5 parts, taurine 1.6 parts, Semen Coicis rice flour 0.8
Part, Poria powder 0.4 part, soybean lecithin 0.9 part and soybean oligo saccharide 0.6 part.
Wherein, biodiversity content≤5% in soybean protein isolate powder, thick protein mass content >=95%, slightly
Fat mass content≤0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
Protein quality content >=86% in whey protein concentrate powder, biodiversity content≤5.5%, butterfat quality contains
Amount≤6%, lactose mass content >=12%.
Protein quality content >=94% in fish collagen protein powder, ash mass content≤5%, total plate count≤2000
cfu/g。
Taurine granularity is 80 mesh, and the granularity of Semen Coicis rice flour and Poria powder is 90 mesh.
The preparation method of the present embodiment whey-soybean albumen composite powder is: by weight by soybean protein isolate powder, breast
Clear concentrated protein powder and fish collagen protein powder mixing, add other component pelletizes by weight through ebullated bed, control
The inlet temperature of ebullated bed is 114 DEG C, and outlet temperature is 76 DEG C, collects product, sterilizing, i.e. prepares finished product.
After the present embodiment sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤
3%, total arsenic≤0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；
Microbiological indicator is: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g,
Salmonella, shigella, staphylococcus aureus must not detect.
The above-mentioned description to embodiment is to be understood that for ease of those skilled in the art and use to send out
Bright.These embodiments obviously easily can be made various amendment by person skilled in the art, and at this
The General Principle illustrated is applied in other embodiments without through performing creative labour.Therefore, the present invention does not limits
In above-described embodiment, those skilled in the art are according to the announcement of the present invention, without departing from changing that scope is made
Entering and revise all should be within protection scope of the present invention.
Claims (10)
1. a whey-soybean albumen composite powder, it is characterised in that this albumen composite powder includes following components and weight
Amount part content: soybean protein isolate powder 5-10 part, whey protein concentrate powder 12-20 part, fish collagen protein powder 3-10
Part and taurine 0.5-2 part.
A kind of whey-soybean albumen composite powder the most according to claim 1, it is characterised in that this albumen is multiple
Close powder and also include Semen Coicis rice flour 0.5-1 part, Poria powder 0.1-1 part, soybean lecithin 0.5-1 part and soybean oligo saccharide
0.2-0.6 part.
A kind of whey-soybean albumen composite powder the most according to claim 2, it is characterised in that this albumen is multiple
Close powder and include following components and weight portion content: soybean protein isolate powder 6.5-9 part, whey protein concentrate powder 12-16
Part, fish collagen protein powder 4.5-8 part, taurine 0.6-1.4 part, Semen Coicis rice flour 0.6-0.7 part, Poria powder 0.1-0.3
Part, soybean lecithin 0.6-0.8 part and soybean oligo saccharide 0.2-0.4 part.
A kind of whey-soybean albumen composite powder the most according to claim 3, it is characterised in that this albumen is multiple
Close powder and include following components and weight portion content: soybean protein isolate powder 6.6 parts, 12 parts of whey protein concentrate powder,
Fish collagen protein powder 4.8 parts, taurine 0.6 part, 0.6 part of Semen Coicis rice flour, Poria powder 0.1 part, soybean lecithin
0.8 part and soybean oligo saccharide 0.2 part.
A kind of whey-soybean albumen composite powder the most according to claim 4, it is characterised in that described is big
Biodiversity content≤5% in bean separated protein powder, thick protein mass content >=95%, crude fat mass content
≤ 0.8%, crude fibre mass content≤0.2%, ash mass content≤4%.
A kind of whey-soybean albumen composite powder the most according to claim 4, it is characterised in that described breast
Protein quality content >=86% in clear concentrated protein powder, biodiversity content≤5.5%, butterfat mass content
≤ 6%, lactose mass content >=12%.
A kind of whey-soybean albumen composite powder the most according to claim 4, it is characterised in that described fish
Protein quality content >=94% in collagen protein powder, ash mass content≤5%, total plate count≤2000cfu/g.
A kind of whey-soybean albumen composite powder the most according to claim 4, it is characterised in that described cattle
The granularity of sulfonic acid is 60-80 mesh, and described Semen Coicis rice flour and the granularity of Poria powder are 80-100 mesh.
The preparation method of a kind of whey-soybean albumen composite powder the most as claimed in claim 1, it is characterised in that
By weight soybean protein isolate powder, whey protein concentrate powder and fish collagen protein powder are mixed, press through ebullated bed
Weight portion adds other component pelletizes, and the inlet temperature controlling ebullated bed is 112-118 DEG C, and outlet temperature is
72-78 DEG C, collect product, sterilizing, i.e. prepare finished product.
The preparation method of a kind of whey-soybean albumen composite powder the most according to claim 9, it is characterised in that
After sterilizing, the physical and chemical index of finished product is: moisture≤3%, butt protein >=85%, ash≤3%, total arsenic≤
0.5mg/kg, aluminum≤1.0mg/kg, AFB1≤5 μ g/kg, urease activity is negative；Microorganism refers to
It is designated as: total plate count≤30000cfu/g, coliform≤30MPN/100g, mycete≤50cfu/g, Salmonella
Bacterium, shigella, staphylococcus aureus must not detect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610272434.6A CN105918607A (en) | 2016-04-28 | 2016-04-28 | Soybean whey protein composite powder and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610272434.6A CN105918607A (en) | 2016-04-28 | 2016-04-28 | Soybean whey protein composite powder and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105918607A true CN105918607A (en) | 2016-09-07 |
Family
ID=56836478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610272434.6A Pending CN105918607A (en) | 2016-04-28 | 2016-04-28 | Soybean whey protein composite powder and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105918607A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279456A (en) * | 2017-06-12 | 2017-10-24 | 钱凤英 | One kind germination soyabean protein powder and preparation method thereof |
| CN107625136A (en) * | 2017-11-09 | 2018-01-26 | 江苏江大五棵松生物科技有限公司 | A kind of complex polypeptide powder for supplementing human body protein |
| CN108617849A (en) * | 2018-05-14 | 2018-10-09 | 余碧芝 | Protein compositions and preparation method thereof containing balanced amino acid |
| CN108618155A (en) * | 2018-05-14 | 2018-10-09 | 余碧芝 | The protein compositions and preparation method thereof of amino acid content equilibrium |
| CN109315663A (en) * | 2018-08-27 | 2019-02-12 | 杭州维洛斯生物科技有限责任公司 | A kind of vanilla flavored albumen composite fermentation fruits and vegetables solid beverage and preparation method thereof |
| CN109953350A (en) * | 2017-12-25 | 2019-07-02 | 山东御膳世家生物科技有限公司 | A kind of recovery albumen peptide nutrient food and preparation method thereof |
-
2016
- 2016-04-28 CN CN201610272434.6A patent/CN105918607A/en active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107279456A (en) * | 2017-06-12 | 2017-10-24 | 钱凤英 | One kind germination soyabean protein powder and preparation method thereof |
| CN107625136A (en) * | 2017-11-09 | 2018-01-26 | 江苏江大五棵松生物科技有限公司 | A kind of complex polypeptide powder for supplementing human body protein |
| CN109953350A (en) * | 2017-12-25 | 2019-07-02 | 山东御膳世家生物科技有限公司 | A kind of recovery albumen peptide nutrient food and preparation method thereof |
| CN108617849A (en) * | 2018-05-14 | 2018-10-09 | 余碧芝 | Protein compositions and preparation method thereof containing balanced amino acid |
| CN108618155A (en) * | 2018-05-14 | 2018-10-09 | 余碧芝 | The protein compositions and preparation method thereof of amino acid content equilibrium |
| CN109315663A (en) * | 2018-08-27 | 2019-02-12 | 杭州维洛斯生物科技有限责任公司 | A kind of vanilla flavored albumen composite fermentation fruits and vegetables solid beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105918607A (en) | Soybean whey protein composite powder and preparation method thereof | |
| Zhu et al. | Effects of soybean meal fermented by L. plantarum, B. subtilis and S. cerevisieae on growth, immune function and intestinal morphology in weaned piglets | |
| CN103355543B (en) | Piglet forage | |
| KR101160730B1 (en) | The egg containing selenium, astaxanthin and DHA and its production method | |
| CN102940151A (en) | Feed for improving egg laying performance of laying duck | |
| CN106689786A (en) | Compound feed for promoting development of muscular stomach of broiler and preparation method of compound feed | |
| WO2011160420A1 (en) | Green milk | |
| CN103907749A (en) | Biological fermentation active carrier type composite premix feed as well as preparation method and application thereof | |
| RU2579219C1 (en) | Feed additives for livestock and poultry | |
| CN106577479A (en) | Yellow calf raising method | |
| CN103519009A (en) | Healthcare sand for pigeons | |
| CN105614860A (en) | Probiotic compound oligopeptide nutritional supplement capable of lowering uric acid | |
| KR20140106274A (en) | Health foods composition for diet and muscle strengthen and manufacturing of the same | |
| CN107223792A (en) | Broiler chicken feed additive and its preparation method and application | |
| Neumann et al. | Contribution of animal source foods in improving diet quality for children in the developing world | |
| CN103535576B (en) | Meal replacement powder containing pollen | |
| CN110664896B (en) | Anti-stress sudden death prevention compound fermentation traditional Chinese medicine additive and preparation method and application thereof | |
| RU2407400C2 (en) | Method to grow chickens, calves and piglets | |
| CN116686876A (en) | Children formula milk powder capable of improving attention and preparation method thereof | |
| RU2348174C1 (en) | Fodder additive for sucking period piglets | |
| CN106234854A (en) | A kind of feedstuff improving crab immunity | |
| CN108432975A (en) | A kind of broiler fodder | |
| CN107647122B (en) | Chinese herbal medicine compound feed additive for fattening beef cattle | |
| KR20210084942A (en) | The manufacturing method of making healthcare food composition for costitutional group | |
| RU2420089C2 (en) | Dietary fodder supplement for broiler chickens |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160907 |